Edition:
India

Avid Bioservices Inc (CDMO.OQ)

CDMO.OQ on NASDAQ Stock Exchange Capital Market

5.01USD
16 Oct 2019
Change (% chg)

-- (--)
Prev Close
$5.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
128,451
52-wk High
$7.15
52-wk Low
$3.39

Latest Key Developments (Source: Significant Developments)

Avid Bioservices Reports Q1 Loss Per Share $0.08
Friday, 6 Sep 2019 

Sept 5 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR FIRST QUARTER FISCAL 2020 AND RECENT DEVELOPMENTS.Q1 LOSS PER SHARE $0.08.SEES FY 2020 REVENUE $64 MILLION TO $67 MILLION.Q1 REVENUE $15.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $14.4 MILLION.REPORTED $28.9 MILLION IN CASH AND CASH EQUIVALENTS AS OF JULY 31, 2019.FY2020 REVENUE VIEW $65.5 MILLION -- REFINITIV IBES DATA.  Full Article

Avid Bioservices Reaffirms Fiscal 2019 Guidance And Announces Upcoming Conference Participation
Thursday, 9 May 2019 

May 9 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES REAFFIRMS FISCAL 2019 GUIDANCE AND ANNOUNCES UPCOMING CONFERENCE PARTICIPATION.FY2019 REVENUE VIEW $52.0 MILLION -- REFINITIV IBES DATA.  Full Article

Avid Bioservices Names Richard Hancock As Interim President And CEO
Thursday, 9 May 2019 

May 8 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES NAMES RICHARD B. HANCOCK AS INTERIM PRESIDENT AND CHIEF EXECUTIVE OFFICER.AVID BIOSERVICES INC - HANCOCK WILL ALSO CONTINUE TO SERVE ON AVID'S BOARD OF DIRECTORS.AVID BIOSERVICES INC - HANCOCK SUCCEEDS ROGER J. LIAS, PH.D., WHO HAS RESIGNED FROM COMPANY AND ITS BOARD OF DIRECTORS.AVID BIOSERVICES INC - IS COMMENCING A SEARCH FOR A PERMANENT CHIEF EXECUTIVE OFFICER..  Full Article

Avid Bioservices Q2 Loss Per Share $0.05
Tuesday, 11 Dec 2018 

Dec 10 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR SECOND QUARTER FISCAL 2019 AND RECENT DEVELOPMENTS.Q2 LOSS PER SHARE $0.05.SEES FY 2019 REVENUE $51 MILLION TO $55 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.08 -- REFINITIV IBES DATA.AVID BIOSERVICES - REVENUE BACKLOG AS OF OCT. 31, 2018 WAS $36 MILLION, MAJORITY OF WHICH IS SEEN RECOGNIZING IN FY 2019.Q2 REVENUE CONTRACT MANUFACTURING REVENUE $10.2 MILLION VERSUS $12.8 MILLION.Q2 REVENUE VIEW $10.9 MILLION -- REFINITIV IBES DATA.  Full Article

Avid Bioservices Q1 Loss Per Share $0.06
Tuesday, 11 Sep 2018 

Sept 10 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR FIRST QUARTER FISCAL 2019 AND RECENT DEVELOPMENTS.SEES FY 2019 REVENUE $51 MILLION TO $55 MILLION.Q1 LOSS PER SHARE $0.06.AVID BIOSERVICES - FISCAL 2019 PROJECTED REVENUE OF $51 MILLION TO $55 MILLION REAFFIRMED.  Full Article

Avid Bioservices Selected By Acumen Pharmaceuticals To Lead Process Development And Clinical Manufacture Of Novel Alzheimer's Disease Candidate
Thursday, 1 Mar 2018 

March 1 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES SELECTED BY ACUMEN PHARMACEUTICALS TO LEAD PROCESS DEVELOPMENT AND CLINICAL MANUFACTURE OF NOVEL ALZHEIMER’S DISEASE CANDIDATE.AVID BIOSERVICES - ACUMEN PHARMA SELECTED CO TO PROVIDE PROCESS DEVELOPMENT, CLINICAL MANUFACTURING SERVICES IN SUPPORT OF ACU193.  Full Article

Avid Bioservices Announces Resignation Of CFO
Monday, 26 Feb 2018 

Feb 26 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER.AVID BIOSERVICES - PAUL LYTLE TO RESIGN AS CFO.AVID BIOSERVICES INC - ‍ SEARCH FOR LYTLE'S REPLACEMENT HAS BEEN INITIATED​.  Full Article

Avid Bioservices Inc Says Paul Lytle Gave Notice Of His Voluntary Resignation As CFO
Saturday, 24 Feb 2018 

Feb 23 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES INC SAYS PAUL LYTLE GAVE NOTICE OF HIS VOLUNTARY RESIGNATION AS CFO OF CO - SEC FILING.AVID BIOSERVICES INC - COMPANY IS INITIATING A SEARCH FOR ITS NEXT CFO.  Full Article

Avid Bioservices Announces Pricing Of Public Offering
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 9.00 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.SAYS PUBLIC OFFERING OF 9.00 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

Avid Bioservices Announces Proposed Offering Of Common Stock
Thursday, 15 Feb 2018 

Feb 14 (Reuters) - Avid Bioservices Inc ::AVID BIOSERVICES ANNOUNCES PROPOSED OFFERING OF COMMON STOCK.AVID BIOSERVICES INC - ‍INTENDS TO USE NET PROCEEDS FROM OFFERING FOR EXPANSION OF ITS CONTRACT MANUFACTURING BUSINESS AND GENERAL CORPORATE PURPOSES​.  Full Article